Please assess the completion status of the following clinical trial:

Trial Title: Ultrasound-Monitored Changes in Achilles Tendinopathy After Extracorporeal Shock Wave Therapy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* the patient complains about Achilles tendon pain, which limits (at least partially) his quality of life during daily activities or sport, and this condition would be referred as a tendinopathy~* the patient's other leg is asymptomatic~* the patient is not aware of the symptomatical mechanical tendon damage in past (eg. partial or complete rupture due to injury)~* the patient has no previous experience with extracorporeal shockwave therapy treatment~Exclusion Criteria:~* the patient has condition which is contraindication for extracorporeal shock wave therapy treatment~* the patient had symptomatical mechanical tendon damage in past (eg. partial or complete rupture due to injury)

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Treatment Group (A) (Type: EXPERIMENTAL): Group of patients with Achilles tendinopathy which are treated by focused extracorporeal shockwave therapy once a week for 5 weeks. ESWT parameters: 0,12 mJ/mm2, 10 Hz, 1300 shocks.
- Sham Group (B) (Type: SHAM_COMPARATOR): Group of patients with Achilles tendinopathy in which sham extracorporeal shockwave therapy is applied once a week for 5 weeks. Total applications are 5, applicated weekly. Sham ESWT parameters are same as in Group A (0,12 mJ/mm2, 10 Hz, 1300 shocks) but with modified applicator which does not allow wave transmission.

Based on this trial design, predict the completion outcome and termination type (if applicable).